Humanity 2.0: The New Normal
Sociologist Steve Fuller says we're headed for a new humanity which will no longer take as given the "normal human body". Our self-enhancements will include 'cosmetic neurology.'
What's the Latest Development?
Sociologist Steve Fuller says we're headed for a new humanity which will no longer take as given the "normal human body". A good example would be cosmetic neurology, which is essentially plastic surgery for the brain. Where you go in every so often and you get a tune-up of your synapses. It's already done at a medical school.
What's the Big Idea?
One implication of all this is that life expectancy won't uniformly go up, Fuller predicts it'll start to be bimodal distribution—some people will live beyond 100 and there'll be a large number of people who die under the age of 70. "That will be because people will definitely take advantage of the enhancements on offer, but others won't have those choices open to them."
International poker champion Liv Boeree teaches decision-making for Big Think Edge.
"I was so moved when I saw the cells stir," said 90-year-old study co-author Akira Iritani. "I'd been hoping for this for 20 years."
- The team managed to stimulate nucleus-like structures to perform some biological processes, but not cell division.
- Unless better technology and DNA samples emerge in the future, it's unlikely that scientists will be able to clone a woolly mammoth.
- Still, studying the DNA of woolly mammoths provides valuable insights into the genetic adaptations that allowed them to survive in unique environments.
An MIT study predicts when artificial intelligence will take over for humans in different occupations.
While technology develops at exponential speed, transforming how we go about our everyday tasks and extending our lives, it also offers much to worry about. In particular, many top minds think that automation will cost humans their employment, with up to 47% of all jobs gone in the next 25 years. And chances are, this number could be even higher and the massive job loss will come earlier.
The blood of horseshoe crabs is harvested on a massive scale in order to retrieve a cell critical to medical research. However, recent innovations might make this practice obsolete.
- Horseshoe crabs' blue blood is so valuable that a quart of it can be sold for $15,000.
- This is because it contains a molecule that is crucial to the medical research community.
- Today, however, new innovations have resulted in a synthetic substitute that may end the practice of farming horseshoe crabs for their blood.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.